|
SLC7A5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.083410E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.101500E-03 |
| Normal-vs-Stage2 |
4.671200E-01 |
| Normal-vs-Stage3 |
1.577000E-01 |
| Normal-vs-Stage4 |
8.080600E-01 |
| Stage1-vs-Stage2 |
3.043600E-01 |
| Stage1-vs-Stage3 |
1.519510E-02 |
| Stage1-vs-Stage4 |
3.474300E-02 |
| Stage2-vs-Stage3 |
9.001600E-02 |
| Stage2-vs-Stage4 |
4.965800E-01 |
| Stage3-vs-Stage4 |
2.698800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.028000E-02 |
| Normal-vs-AfricanAmerican |
5.711200E-01 |
| Normal-vs-Asian |
4.105200E-01 |
| Caucasian-vs-AfricanAmerican |
1.908000E-01 |
| Caucasian-vs-Asian |
7.795200E-01 |
| AfricanAmerican-vs-Asian |
5.833200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.921500E-02 |
| Normal-vs-Female |
4.906800E-01 |
| Male-vs-Female |
8.511700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.753600E-01 |
| Normal-vs-Extreme_Weight |
1.833920E-02 |
| Normal-vs-Obese |
3.354200E-01 |
| Normal-vs-Extreme_Obese |
2.551800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.795620E-01 |
| Normal_Weight-vs-Obese |
7.892000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.604800E-01 |
| Extreme_Weight-vs-Obese |
1.319620E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.485000E-01 |
| Obese-vs-Extreme_Obese |
7.365200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.155000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.284200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.241500E-03 |
| Normal-vs-Age(81-100Yrs) |
2.593200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.008630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.578300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.569800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.203990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.638550E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.835810E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.203200E-04 |
| Normal-VS-Type2 PRCC |
6.752600E-01 |
| Normal-VS-KIRP CIMP |
9.368200E-04 |
| Normal-VS-Unclassified PRCC |
5.015400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.300700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.481410E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.845840E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.136500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.161200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.263470E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.897000E-01 |
| Normal-vs-N1 |
2.537000E-01 |
| Normal-vs-N2 |
6.902400E-01 |
| N0-vs-N1 |
3.188800E-01 |
| N0-vs-N2 |
8.419600E-01 |
| N1-vs-N2 |
7.709800E-01 |
|
|
